We've found
184,457
clinical trials
We've found
184,457
clinical trials
Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 12/31/1969
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 12/31/1969
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Esophageal Neoplasms Clinical Trial
Updated: 12/31/1969
First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Treatment Naive Follicular Lymphoma Clinical Trial
Updated: 12/31/1969
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Treatment Naive Follicular Lymphoma Clinical Trial
Updated: 12/31/1969
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Treatment Naive Follicular Lymphoma Clinical Trial
Updated: 12/31/1969
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hypertension Clinical Trial
Updated: 12/31/1969
Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Female Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Cancer Female Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Psychiatry / Psychology, Reproductive Clinical Trial
Updated: 12/31/1969
A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Malignant Solid Tumour Clinical Trial
Updated: 12/31/1969
Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Patients With Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Unhealthy Alcohol Use Clinical Trial
Updated: 12/31/1969
Financial Incentives, Randomization With Stepped Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Antibody-mediated Rejection Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Painful Diabetic Neuropathy Clinical Trial
Updated: 12/31/1969
Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

HER2-positive Breast Cancer Clinical Trial
Updated: 12/31/1969
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Feeding Behavior Clinical Trial
Updated: 12/31/1969
Effect of Varying Proportions of Low and High Energy Dense Foods Over 5 Days in Preschool Children
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Registry of Outcomes From AntiReflux Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Registry of Outcomes From AntiReflux Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Urinary Stones Clinical Trial
Updated: 12/31/1969
Prevention of Urinary Stones With Hydration
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
